Literature DB >> 11286661

Metabolic Complications of HIV and AIDS.

Alison Strawford, Marc K. Hellerstein.   

Abstract

Nutritional problems in the patient with HIV/AIDS may include both wasting and the more recently described lipodystrophy syndromes, which are complex disorders of body composition and metabolism associated with antiretroviral therapy. In this paper we review the pathophysiology and treatment options for both wasting and lipodystrophy.

Entities:  

Year:  2001        PMID： 11286661     DOI： 10.1007/s11908-996-0057-x

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


  52 in total

Review 1.  Fat distribution and metabolic changes in patients with HIV infection.

Authors:  S Safrin; C Grunfeld
Journal:  AIDS       Date:  1999-12-24       Impact factor: 4.177

2.  A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

Authors:  T Saint-Marc; M Partisani; I Poizot-Martin; F Bruno; O Rouviere; J M Lang; J A Gastaut; J L Touraine
Journal:  AIDS       Date:  1999-09-10       Impact factor: 4.177

3.  Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

Authors:  M Schambelan; K Mulligan; C Grunfeld; E S Daar; A LaMarca; D P Kotler; J Wang; S A Bozzette; J B Breitmeyer
Journal:  Ann Intern Med       Date:  1996-12-01       Impact factor: 25.391

4.  Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine.

Authors:  E Martínez; I Conget; L Lozano; R Casamitjana; J M Gatell
Journal:  AIDS       Date:  1999-05-07       Impact factor: 4.177

5.  A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

Authors:  A Carr; J Miller; M Law; D A Cooper
Journal:  AIDS       Date:  2000-02-18       Impact factor: 4.177

Review 6.  Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

Authors:  T N Kakuda
Journal:  Clin Ther       Date:  2000-06       Impact factor: 3.393

7.  Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome.

Authors:  D P Kotler; A R Tierney; J A Culpepper-Morgan; J Wang; R N Pierson
Journal:  JPEN J Parenter Enteral Nutr       Date:  1990 Sep-Oct       Impact factor: 4.016

8.  A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Authors:  A Carr; K Samaras; S Burton; M Law; J Freund; D J Chisholm; D A Cooper
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

9.  The effect of protease inhibitors on weight and body composition in HIV-infected patients.

Authors:  M Silva; P R Skolnik; S L Gorbach; D Spiegelman; I B Wilson; M G Fernández-DiFranco; T A Knox
Journal:  AIDS       Date:  1998-09-10       Impact factor: 4.177

10.  Effects of dietary n-3 fatty acid supplementation in men with weight loss associated with the acquired immune deficiency syndrome: Relation to indices of cytokine production.

Authors:  M K Hellerstein; K Wu; M McGrath; D Faix; D George; C H Shackleton; W Horn; R Hoh; R A Neese
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.